NSE:MARKSANS shows strong buy indicated by PSAR, MACD & Fisher crossover followed by EMA & MA Crossover
Target 1: 72.55
Target 2: 64.95
Stop Loss: 55.60
The analysis is only for illustration purposes only. Please consult your financial advisor, agent, broker before acting on any information. We may or may not have positions in the stock and our...
Potential Opportunity as Swing Trade in NSE:MARKSANS
Risk : Reward - 1:2
ENTRY - 57.50
TARGET - 64.70
STOP LOSS - 53.80
This is for Educational Purpose only, apply your prudence & consult your adviser before any investing.
#nse #swingtrade #nifty #marksans #marksanspharma #nifty50 #priceaction #supportzone #trendline #retest...
MARKSANS PHARMA great stock to buy now at discounted price
2x of book value👍
dividend yield half percent👍
look at ROCE almost 40% and ROE 32% fantastic for a company 💪💪💪
recently the company has reduced its debt its has only little debt
important factor to watch out is the pe ration which is very less in indutry average almost all the...
This is my view on MARKSANS;
CMP 69.85 | T1: 98 (~40%) | T2: 108 (~55%)
The rationale for the going long:
- Stock moves up with high volumes and pullback occur with lower volumes.
- Base formation (consolidation) at 66-69 Levels
- RSI Bullish Divergence.
- Highest revenue and net profits in FY 2021 & TTM QE June 2021 (in past 10years).
- Low PE of ~11 compared to...
This is only for educational purpose
This is not a recommendation
I am not SEBI registered
Do not TRADE/INVEST basis what I publish here
I am not responsible for your loss or gain
It is prudent to assume that I have ulterior motives in publishing this Idea
I and my clients might or might not have a position, I and my clients might or might not...
Marksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. Its product portfolio spreads over major therapeutic areas such as oncology, gastroenterology, anti-diabetic, cardiovascular, pain management, and gynecology. The company was founded by Mark Bosco Saldanha on April 16, 1992 and is headquartered in Mumbai,...